Artificial intelligence continues to deliver on its promise to improve patient care with a new tool that helps radiologists better spot breast cancers on mammograms, a study published Wednesday demonstrates.
Screening mammography is a well-trusted exam that’s proven to detect disease before it spreads, improving prognosis and reducing mortality. At the same time, many cancers are overlooked in the process and others turn out to be benign, researchers explained Nov. 4 in Radiology: Artificial Intelligence.
A new device, known as MammoScreen, however, boosted radiologists’ average sensitivity for spotting breast cancers and also decreased their rate of false negatives, said Serena Pacilè, PhD, clinical research manager at Therapixel, a Valbonne, France-based company that developed the software.